Drugs have long been a cross-border phenomenon. As drug problems in Europe are increasingly linked to, and influenced by, global developments, it is crucial that our analysis of trends and developments be placed in the wider international context. This is why working with external partners is a key area of our work, increasing our understanding of the external dimension of the drug phenomenon as well as boosting our preparedness to react quickly to new threats. 30.03.2020
Čtěte více
Čtěte více
What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the frontline? These are among the questions raised in a new EMCDDA update published today. 23.03.2020
Čtěte více
Čtěte více
EMCDDA staff members will be switching to teleworking today following a decision by its Director Alexis Goosdeel (1). The decision comes as the COVID-19 pandemic continues to intensify and as the EU and its Member States adopt new precautionary measures. 16.03.2020
Čtěte více
New study on wastewater analysis shines light on city drug use 10.03.2020
The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1). The project analysed wastewater in 68 cities in 23 European countries to explore the drug-taking behaviours of their inhabitants.
Čtěte více
